A phase II trial of sequential MTx and 5-FU alternated with 4-epidoxorubicin and cisplatin in advanced gastric cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/2265372

Download in:

View as

General Info

PMID
2265372